Knock-Out Finder
Your selection:
51 Results
| DY39K2 | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 20.000 | 20.000 | - | 75.535% | - | DZ Bank | ||
| DY39K3 | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 22.000 | 22.000 | - | 73.089% | - | DZ Bank | ||
| DY39K4 | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 24.000 | 24.000 | - | 70.642% | - | DZ Bank | ||
| DY39K5 | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 26.000 | 26.000 | - | 68.196% | - | DZ Bank | ||
| DY39K6 | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 28.000 | 28.000 | - | 65.749% | - | DZ Bank | ||
| DY39K7 | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 30.000 | 30.000 | - | 63.303% | - | DZ Bank | ||
| DY39K8 | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 32.000 | 32.000 | - | 60.856% | - | DZ Bank | ||
| DY39K9 | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 34.000 | 34.000 | - | 58.410% | - | DZ Bank | ||
| DY39LA | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 35.000 | 35.500 | - | 56.575% | - | DZ Bank | ||
| DY39LB | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 36.000 | 36.000 | - | 55.963% | - | DZ Bank | ||
| DY39LC | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 38.000 | 38.000 | - | 53.517% | - | DZ Bank | ||
| DY39LD | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 40.000 | 40.000 | - | 51.070% | - | DZ Bank | ||
| DY39LE | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 40.000 | 40.500 | - | 50.459% | - | DZ Bank | ||
| DY39LF | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 42.000 | 42.000 | - | 48.624% | - | DZ Bank | ||
| DY39LG | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 44.000 | 44.000 | - | 46.177% | - | DZ Bank | ||
| DY39LH | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 45.000 | 45.500 | - | 44.343% | - | DZ Bank | ||
| DY39LJ | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 46.000 | 46.000 | - | 43.731% | - | DZ Bank | ||
| DY39LK | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 48.000 | 48.000 | - | 41.284% | - | DZ Bank | ||
| DY39LL | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 50.000 | 50.000 | - | 38.838% | - | DZ Bank | ||
| DY39LM | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 50.000 | 50.500 | - | 38.226% | - | DZ Bank | ||
| DY39LN | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 52.000 | 52.000 | - | 36.391% | - | DZ Bank | ||
| DY39LP | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 54.000 | 54.000 | - | 33.945% | - | DZ Bank | ||
| DY39LQ | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 55.000 | 55.500 | - | 32.110% | - | DZ Bank | ||
| DY39LR | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 56.000 | 56.000 | - | 31.498% | - | DZ Bank | ||
| DY39LS | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 58.000 | 58.000 | - | 29.052% | - | DZ Bank | ||
| DY39LT | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 60.000 | 60.000 | - | 26.606% | - | DZ Bank | ||
| DY39LU | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 60.000 | 60.500 | - | 25.994% | - | DZ Bank | ||
| DY39LV | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 62.000 | 62.000 | - | 24.159% | - | DZ Bank | ||
| DY39LW | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 64.000 | 64.000 | - | 21.713% | - | DZ Bank | ||
| DY39LX | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 65.000 | 65.500 | - | 19.878% | - | DZ Bank | ||
| DY39LY | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 66.000 | 66.000 | - | 19.266% | - | DZ Bank | ||
| DY39LZ | BridgeBio Pharma Inc./KO/Call [endlos]/DZ | - | - | call | BridgeBio Pharma Inc. | 68.000 | 68.000 | - | 16.820% | - | DZ Bank | ||
| MD0VC0 |  | BridgeBio Pharma Inc./Faktor/Long [2]/MS | - | - | call | BridgeBio Pharma Inc. | 40.386 | 40.386 | 2.006 | 50.598% | - | Morgan Stanley | |
| MG0JPB | | BridgeBio Pharma Inc./Faktor/Long [3]/MS | - | - | call | BridgeBio Pharma Inc. | 53.852 | 53.852 | 3.030 | 34.126% | - | Morgan Stanley | |
| MG3VV3 | | BridgeBio Pharma Inc./Faktor/Long [6]/MS | - | - | call | BridgeBio Pharma Inc. | 67.315 | 67.315 | 6.004 | 17.657% | - | Morgan Stanley | |
| MG6X20 | | BridgeBio Pharma Inc./Faktor/Long [5]/MS | - | - | call | BridgeBio Pharma Inc. | 64.623 | 64.623 | - | 20.951% | - | Morgan Stanley | |
| MJ42F2 | | BridgeBio Pharma Inc./Faktor/Long [4]/MS | - | - | call | BridgeBio Pharma Inc. | 60.584 | 60.584 | - | 25.892% | - | Morgan Stanley | |
| MK4BK7 | | BridgeBio Pharma Inc./Faktor/Long [5]/MS | - | - | call | BridgeBio Pharma Inc. | 64.623 | 64.623 | - | 20.951% | - | Morgan Stanley | |
| MM6SPY | | BridgeBio Pharma Inc./Faktor/Short [2]/MS | - | - | put | BridgeBio Pharma Inc. | 121.137 | 121.137 | 1.879 | 48.180% | - | Morgan Stanley | |
| MM6SPZ | | BridgeBio Pharma Inc./Faktor/Short [3]/MS | - | - | put | BridgeBio Pharma Inc. | 107.677 | 107.677 | 2.909 | 31.715% | - | Morgan Stanley | |
| MM6SQ0 | | BridgeBio Pharma Inc./Faktor/Short [4]/MS | - | - | put | BridgeBio Pharma Inc. | 100.947 | 100.947 | - | 23.483% | - | Morgan Stanley | |
| MN5GF5 | | BridgeBio Pharma Inc./Faktor/Short [5]/MS | - | - | put | BridgeBio Pharma Inc. | 96.910 | 96.910 | - | 18.544% | - | Morgan Stanley | |
| MR3H7P | | BridgeBio Pharma Inc./Faktor/Long [4]/MS | - | - | call | BridgeBio Pharma Inc. | 60.584 | 60.584 | - | 25.892% | - | Morgan Stanley | |
| MR47CG | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 42.038 | 42.038 | 2.030 | 48.577% | - | Morgan Stanley | |
| MR47CH | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 44.040 | 44.040 | 2.147 | 46.129% | - | Morgan Stanley | |
| MR47CJ | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 46.042 | 46.042 | 2.255 | 43.680% | - | Morgan Stanley | |
| MR47CK | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 48.043 | 48.043 | 2.388 | 41.231% | - | Morgan Stanley | |
| MR47CL | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 50.045 | 50.045 | 2.535 | 38.783% | - | Morgan Stanley | |
| MR47CM | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 52.047 | 52.047 | 2.725 | 36.334% | - | Morgan Stanley | |
| MR47CN | | BridgeBio Pharma Inc./KO/Call [endlos]/MS | - | - | call | BridgeBio Pharma Inc. | 54.049 | 54.049 | 2.904 | 33.885% | - | Morgan Stanley |